Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus

被引:29
|
作者
Witte, T
Hartung, K
Matthias, T
Sachse, C
Fricke, M
Deicher, H
Kalden, JR
Lakomek, HJ
Peter, HH
Schmidt, RE
机构
[1] Med Hsch Hannover, Abt Klin Immunol, D-30625 Hannover, Germany
[2] Zent Krankenhaus Reinkenheide, Inst Lab & Transfus Med, D-27574 Bremerhaven, Germany
[3] ORGenTec Diagnost Gmbh, D-55116 Mainz, Germany
[4] Med Hsch Hannover, Abt Klin Chem 2, D-30659 Hannover, Germany
[5] FAU Erlangen Nurnberg, Med Klin 3, D-91054 Erlangen, Germany
[6] Klin Rheumatol & Phys Med, D-32427 Minden, Germany
[7] Univ Freiburg, Med Klin, Abt Rheumatol & Klin Immunol, D-79106 Freiburg, Germany
关键词
systemic lupus erythematosus; lupus; anti-dsDNA antibodies; IgA;
D O I
10.1007/s002960050059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previously it has been suggested that the presence of antibodies against dsDNA of the IgA class may define a subset of systemic lupus erythematosus (SLE) patients suffering from nephritis and arthritis. Therefore, these autoantibodies were measured in sera of 352 patients with SLE, 81 blood donors, and 189 patients with rheumatoid arthritis using a new ELISA based on human recombinant dsDNA as antigen. IgA anti-dsDNA antibodies were found in 19.9% of the sera from patients with SLE, but in none of the sera from 81 normal controls and 189 patients with rheumatoid arthritis. The association of these autoantibodies with 31 clinical and 36 laboratory parameters was calculated. IgA anti-dsDNA antibodies were found to be associated with parameters of disease activity such as elevated erythrocyte sedimentation rate and consumption of complement component C3, and the clinical parameters vasculitis, acral necrosis and erythema, but not with nephritis and arthritis. Therefore, IgA anti-dsDNA antibodies define a subset of SLE patients, and monitoring of IgA anti-dsDNA antibodies may be helpful as a prognostic parameter in patients with SLE.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [21] What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3
    Flechsig, A.
    Rose, T.
    Barkhudarova, F.
    Strauss, R.
    Klotsche, J.
    Daehnrich, C.
    Schlumberger, W.
    Enghard, P.
    Burmester, G-R
    Hiepe, F.
    Biesen, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (04) : 598 - 606
  • [22] Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus
    van den Berg, L
    Nossent, H
    Rekvig, O
    CLINICAL RHEUMATOLOGY, 2006, 25 (03) : 347 - 352
  • [23] Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus
    Loes van den Berg
    Hans Nossent
    Ole Rekvig
    Clinical Rheumatology, 2006, 25 : 347 - 352
  • [24] Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
    Shang, Xiaoying
    Ren, Lisheng
    Sun, Guirong
    Yu, Teng
    Yao, Yuan
    Wang, Lin
    Liu, Fenghai
    Zhang, Lijun
    He, Xiaqin
    Liu, Mingjun
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (02) : 407 - 418
  • [25] BioPlex 2200 multiplexed system: Simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus
    Bardin, Nathalie
    Desplat-Jego, Sophie
    Daniel, Laurent
    Chiche, Noemie Jourde
    Sanmarco, Marielle
    AUTOIMMUNITY, 2009, 42 (01) : 63 - 68
  • [26] ANTI-DSDNA ANTIBODIES IN LABORATORY WORKERS HANDLING BLOOD FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    ZARMBINSKI, MA
    MESSNER, RP
    MANDEL, JS
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (09) : 1380 - 1384
  • [27] Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus
    Tyden, H.
    Lood, C.
    Gullstrand, B.
    Jonsen, A.
    Ivars, F.
    Leanderson, T.
    Bengtsson, A. A.
    LUPUS, 2017, 26 (02) : 139 - 149
  • [28] B CELL POLYGENIC RISK SCORES ASSOCIATED WITH ANTI-DSDNA ANTIBODIES AND NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Hedenstedt, A.
    Reid, S.
    Sayadi, A.
    Eloranta, M. L.
    Skoglund, E.
    Bolin, K.
    Frodlund, M.
    Lerang, K.
    Jonsen, A.
    Dahlqvist, S. Rantapaa
    Bengtsson, A.
    Rudin, A.
    Molberg, O.
    Sjowall, C.
    Sandling, J.
    Leonard, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 68 - 68
  • [29] The Clinical Utility of Measuring Complement and Anti-dsDNA Antibodies During Pregnancy in Patients with Systemic Lupus Erythematosus
    Clowse, Megan E. B.
    Magder, Laurence S.
    Petri, Michelle
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1012 - 1016
  • [30] Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus
    Mora, Claudia
    Medina-Rosas, Jorge
    Maria Santos, Ana
    Jaimes, Diego A.
    Arbelaez, Ana M.
    Romero, Consuelo
    Cortes, Annie
    Londono, John
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1657 - 1664